Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Nippon Chemiphar Sees Profits Halved
Sales Drop 4% Due To Japanese NHI Drug Price Revisions
Mar 20 2020
•
By
Akriti Seth
The firm’s declining sales and profits have led it to slash its forecasts • Source: Shutterstock
More from Earnings
More from Business